Feeds

People of Weight™ hail fat-busting miracle pill

A 'mouth-watering prospect'

  • alert
  • submit to reddit

Secure remote control for conventional and virtual desktops

A miracle fat-busting pill which also helps people quit smoking and cuts harmful cholesterol levels has been hailed as a "mouth-watering prospect" for British GPs after two years' successful trials.

That's the verdict on rimonabant by David Haslam of the National Obesity Forum, who enthused: "This is a completely unique drug and these are very impressive results. It reduces weight, helps in quitting smoking and brings cholesterol levels down. We can really save some lives with this, as well as reducing the large costs of treating obesity and its related complications such as heart disease in the NHS."

Rimonabant works by targeting those bits of the brain which control appetite and will power. It was tested on 3000 people in the US and Canada and after two years on 20mg of the stuff, nearly two-thirds of the guinea pigs had lost weight compared to just one third of those who were on a placebo.

The drug - manufactured by Sanofi-Synthelabo under the trade name Acomplia - could be available in the UK within 18 months, which is when we reckon the real trouble starts. While it is not yet clear whether rimonabant will have positive side-effects including saving the whale and promoting peace in the Middle East, one thing is certain: global economic recession caused by the complete collapse of the junk food industry.

We can well imagine the sight of millons of former burger-flippers begging on street corners. True, they'll be lean, non-smoking former burger-flippers and will at least have the consolation that they do not have to raise funds to satisfy their appetite for chicken-in-a-bucket, fries and cigarettes, but the chilling scale of the human tragedy can only be imagined. ®

Related stories

Peruvians develop super-tasty guinea pig
S'kiddies munch Burger King
Brits move into edible Colombian ant market

Next gen security for virtualised datacentres

More from The Register

next story
Vulture 2 takes a battering in 100km/h test run
Still in one piece, but we're going to need MORE POWER
TRIANGULAR orbits will help Rosetta to get up close with Comet 67P
Probe will be just 10km from Space Duck in October
Boffins ID freakish spine-smothered prehistoric critter: The CLAW gave it away
Bizarre-looking creature actually related to velvet worms
CRR-CRRRK, beep, beep: Mars space truck backs out of slippery sand trap
Curiosity finds new drilling target after course correction
What does a flashmob of 1,024 robots look like? Just like this
Sorry, Harvard, did you say kilobots or KILLER BOTS?
NASA's rock'n'roll shock: ROLLING STONE FOUND ON MARS
No sign of Ziggy Stardust and his band
Why your mum was WRONG about whiffy tattooed people
They're a future source of RENEWABLE ENERGY
Vulture 2 spaceplane autopilot brain surgery a total success
LOHAN slips into some sexy bespoke mission parameters
Another step forward for diamond-based quantum computers
Square cut or pear-shaped, these qubits don't lose their shape
prev story

Whitepapers

5 things you didn’t know about cloud backup
IT departments are embracing cloud backup, but there’s a lot you need to know before choosing a service provider. Learn all the critical things you need to know.
Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Build a business case: developing custom apps
Learn how to maximize the value of custom applications by accelerating and simplifying their development.
Rethinking backup and recovery in the modern data center
Combining intelligence, operational analytics, and automation to enable efficient, data-driven IT organizations using the HP ABR approach.
Next gen security for virtualised datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.